Celling Biosciences ART BMC
Celling Biosciences takes a systematic approach of tissue collection, processing and concentrating cells to address the clinical needs of physicians proving autologous cell therapy to their patients. The Autologous Regenerative Therapies (ART) product portfolio was designed for the optimal processing of tissue at the point of care to isolate certain cells for autologous cellular collection. Our ART BMC systems process autologous bone marrow concentrate effectively and efficiently at point-of-care.
Celling Biosciences takes a systematic approach of tissue collection, processing and concentrating cells to address the clinical needs of physicians proving autologous cell therapy to their patients. The Autologous Regenerative Therapies (ART) product portfolio was designed for the optimal processing of tissue at the point of care to isolate certain cells for autologous cellular collection. Our ART BMC systems process autologous bone marrow concentrate effectively and efficiently at point-of-care.
Celling Biosciences takes a systematic approach of tissue collection, processing and concentrating cells to address the clinical needs of physicians proving autologous cell therapy to their patients. The Autologous Regenerative Therapies (ART) product portfolio was designed for the optimal processing of tissue at the point of care to isolate certain cells for autologous cellular collection. Our ART BMC systems process autologous bone marrow concentrate effectively and efficiently at point-of-care.